Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-10 Boyce Sarah Director Grant or award +831 2,262
2020-06-10 Boyce Sarah Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 Davis Todd C Director Grant or award +831 50,305
2020-06-10 Davis Todd C Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 Gray Nancy Ryan Director Grant or award +831 3,072
2020-06-10 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 KOZARICH JOHN W Director Grant or award +831 27,208
2020-06-10 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 LAMATTINA JOHN L Director Grant or award +831 24,768
2020-06-10 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-10 Patel Sunil Director Grant or award +831 27,190
2020-06-10 Patel Sunil Director Grant or award · Non-Qualified Stock Option (right to buy) +2,468 2,468
2020-06-04 Berkman Charles S SVP, Gen. Counsel & Secretary Sale −11,146 $118.59 $1.3M 40,877
2020-03-13 FOEHR MATTHEW W President and COO Option exercise +2,000 $21.92 $44K 157,449
2020-03-13 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −2,000 64,625
2020-02-27 FOEHR MATTHEW W President and COO Option exercise +7,225 $14.47 $105K 160,968
2020-02-27 FOEHR MATTHEW W President and COO Sale −7,225 $110.00 $795K 153,743
2020-02-27 FOEHR MATTHEW W President and COO Option exercise +1,706 $21.92 $37K 155,449
2020-02-27 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −7,225 7,225
2020-02-27 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,706 66,625

Page 39 of 43 · 858 trades